Raffi Tonikian
About Raffi Tonikian
Raffi Tonikian is the Director of Translational Biomarkers at AbCellera, where he has worked since 2022. He has extensive experience in the pharmaceutical industry, including roles at Merck, Novartis, and Biogen Idec, and holds a PhD in Molecular Genetics from the University of Toronto.
Current Role at AbCellera
Raffi Tonikian serves as the Director of Translational Biomarkers at AbCellera, a position he has held since 2022. In this role, he focuses on the integration of biomarkers in drug development, utilizing his expertise to enhance translational medicine initiatives. His responsibilities include overseeing projects that bridge the gap between laboratory research and clinical applications, ensuring that biomarker strategies align with therapeutic goals.
Previous Experience at Merck
Before joining AbCellera, Raffi Tonikian worked at Merck in various capacities. He served as the Global Director of Medical Affairs for Biomarkers and Companion Diagnostics from 2019 to 2021. Prior to that, he was the Associate Director of Immuno-Oncology Biomarkers and Companion Diagnostics from 2016 to 2019. His tenure at Merck included a brief role as Oncology Director in 2021, where he contributed to oncology projects in Montreal, Quebec.
Educational Background
Raffi Tonikian earned his PhD in Molecular Genetics from the University of Toronto, completing his studies from 2002 to 2009. He also holds a Bachelor of Science degree in Honours Chemistry and Biochemistry from Concordia University, where he studied from 1999 to 2002. His academic background provides a strong foundation for his work in translational medicine and biomarker research.
Professional Experience in Neuroscience and Biotech
Raffi Tonikian has a diverse background in the biotechnology and pharmaceutical industries. He worked at Novartis as a Medical Advisor in Neuroscience from 2015 to 2016 and as a Medical Science Liaison from 2013 to 2015. Additionally, he has experience as a Scientist I at Biogen Idec from 2010 to 2013 and as a Visiting Scientist at Genentech from 2004 to 2005. This varied experience has equipped him with a comprehensive understanding of drug development processes.
Skills and Expertise
Raffi Tonikian possesses strong skills in scientific writing and public speaking, which facilitate the communication of complex scientific concepts. He has expertise in antibody engineering, a critical aspect of translational medicine and drug development. His experience in multi-disciplinary environments enhances his ability to lead translational medicine projects effectively.